Trials

Open-label , single-arm, phase II study of bevacizumab (Avastin) in combination with alternating Xeliri and Xelox as first-line treatment of patients with metastatic colorectal cancer

Cancer type: Colorectal cancer

Phase: II

Principal Investigator: Ă–sterlund Pia

Country: FI

Keywords: Colorectal cancer, Finland

Status: Inclusion completed

Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01531595?term=Osterlund%2C+pia&rank=2